Who is sponsoring NCT04167215?

NCT04167215 is sponsored by Assiut University.

What drugs are being tested in NCT04167215?

Interventions in NCT04167215: superior gluteal artery flap and lumbar artery falp, The gluteal pocket, infragluteal dermal lifiting flap.

What condition does NCT04167215 study?

NCT04167215 studies Body Contouring.

Is NCT04167215 still recruiting?

NCT04167215 is currently status unknown. Last updated 1 April 2021.

Last reviewed 2021-04-01 · How we verify

NCT04167215

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aesthetic Analysis of Gluteal Deformity After Weight Loss and Assessment the Role of Autologous Tissue Augmentation for Gluteal Contouring

Status unknown NA Last updated 1 April 2021

What this trial tests

NA trial testing superior gluteal artery flap and lumbar artery falp in Body Contouring in 100 participants. Status unknown.

Timeline

1 May 2021

Primary endpoint
1 December 2023

1 January 2024

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	100
Start date	1 May 2021
Primary completion	1 December 2023
Estimated completion	1 January 2024

Drugs / interventions tested

superior gluteal artery flap and lumbar artery falp
The gluteal pocket
infragluteal dermal lifiting flap

Conditions studied

Body Contouring — all drugs for Body Contouring →

Sponsor

Assiut University

Who can join

Adults 18 to 50, female only, with Body Contouring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this study aim to evaluate the role of autologous augmentation for buttock contouring and analyze different aethetic gluteal deformity

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04167215 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 1 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04167215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing